Lilly’s Cialis plus Merck’s Proscar yields BPH symptom improvement
This article was originally published in Scrip
Executive Summary
In an ongoing bid to boost the prospects of its Cialis (tadalafil) franchise, Eli Lilly has Phase III data showing that co-administering the drug with finasteride (Merck's Proscar) could improve lower urinary tract symptoms (LUTS) in men with of benign prostatic hyperplasia (BPH) and enlarged prostates. Lilly has not indicated how or if it plans to respond to the findings.